ANDERSON BB. INVESTIGATIONS INTO THE EUGLENA METHOD FOR THE ASSAY OF THE VITAMIN B12 IN SERUM.
J Clin Pathol 1996;
17:14-26. [PMID:
14099996 PMCID:
PMC480664 DOI:
10.1136/jcp.17.1.14]
[Citation(s) in RCA: 144] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Details are given of a modified Euglena method for the assay of B(12) in serum. Serum in very small quantities is usually inhibitory to the growth of the Euglena. In general, this inhibition is most marked when the organism is growing prolifically. For estimating serum B(12) values, a standard curve is used from B(12) standards containing 0.01 ml. of serum of low B(12) content, so that growth in test serum solutions is compared with growth in serum-containing standards. The recovery of B(12) added to serum, incomplete when estimated from aqueous standards, is now complete and the variation in results from batch to batch is markedly reduced. Various factors-such as medium, light, and inoculum-can affect growth in aqueous and serum solutions differently and are an important cause of variations between batches and laboratories. Optimal conditions were studied and they are essential for the most sensitive and accurate assay, but if the results are estimated from serum-containing standards accurate values can be obtained even under less than optimal conditions. Subnormal serum B(12) concentrations can be detected visually as early as 24 hours after the start of assay. For diagnostic purposes the assay can be read at three days, provided that appropriate dilutions are used, conditions are optimal, and growth is measured in a 1 cm. cell.
Collapse